aimed analytics GmbH

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

aimed analytics GmbH - overview

Established

2021

Location

Bergisch Gladbach, North Rhine Westphalia, Germany

Primary Industry

Healthcare IT

About

Based in Germany, aimed analytics GmbH offers an AI-driven bioinformatics platform that simplifies the analysis of omics data, enabling researchers in the life sciences sector to extract insights efficiently. aimed analytics GmbH, founded in 2021, operates from Bergisch Gladbach, Germany, focusing on developing bioinformatics solutions. The company has completed 1 deal to date, with its most recent deal occurring on September 9, 2025. Aimed Analytics specializes in providing an AI-driven bioinformatics platform designed to streamline the analysis of omics data for researchers in the life sciences sector.


The core product leverages artificial intelligence to simplify complex bioinformatics tasks, enabling users to extract insights from their data without needing advanced coding skills. This user-friendly platform allows researchers to upload data easily, ask straightforward questions, and receive AI-generated analyses along with interactive visualizations. Aimed Analytics targets a diverse client base, including academic institutions, research hospitals, and biotech companies across various geographical markets in Europe, Asia, and North America, providing solutions for a range of medical challenges and research projects. Aimed Analytics operates primarily through a subscription-based revenue model, where clients pay for access to their bioinformatics platform and its suite of services.


This structure is designed to cater to both individual researchers and larger institutions, ensuring flexible access depending on the scale of usage. The company may also engage in partnerships with research organizations and biotech firms to provide tailored solutions, further enhancing its revenue stream. Specific pricing plans for their products or services are structured to accommodate varying needs, although detailed figures have not been disclosed. Overall, the revenue generation framework supports continuous innovation and development within their platform, aligning with the evolving demands of the life sciences sector.


In September 2025, aimed analytics GmbH raised an undisclosed amount of venture funding co-led by Prometis Analytics and Pi-Holding GmbH. The company will utilize this funding to develop its self-service platform and expand partnerships, aiming for further growth in its offerings and market reach.


Primary Industry

Healthcare IT

Sub Industries

Molecular Science, Genetics & Gene Therapy, Bioinformatics, Healthcare IT, Analytics & Performance Software, Medical Software

Website

www.aimed-analytics.com/

Verticals

Artificial Intelligence, HealthTech

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.